← FDA Drug Approvals (Drugs@FDA)

BUTALBITAL, ASPIRIN AND CAFFEINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LGM PHARMA · Approved 2021-10-18

Drug application

FDA Application #

ANDA205230

Application type

Abbreviated New Drug Application (Generic)

Brand name

BUTALBITAL, ASPIRIN AND CAFFEINE

Generic name

BUTALBITAL, ASPIRIN, AND CAFFEINE

Active ingredients

ASPIRIN; BUTALBITAL; CAFFEINE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

LGM PHARMA

Manufacturer

LGM PHARMA SOLUTIONS, LLC

First approval

2021-10-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown